Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Total Assets of $355.95 million for the year ending 2025.
- CAPRICOR THERAPEUTICS, INC. showed an increase of +108.8% in Total Assets from 2024 to 2025.
- This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $3.70 million | Q3 2011: $3.09 million | Q1 2012: $716.0 thousand | Q3 2012: $495.2 thousand | Q1 2013: $415.3 thousand | Q2 2013: $294.8 thousand | Q3 2013: $114.4 thousand | Q1 2014: $15.98 million | Q2 2014: $18.44 million | Q3 2014: $16.28 million | Q1 2015: $27.47 million | Q2 2015: $23.69 million | Q3 2015: $19.88 million | Q1 2016: $16.98 million | Q2 2016: $13.89 million | Q3 2016: $24.47 million | Q1 2017: $14.07 million | Q2 2017: $14.22 million | Q3 2017: $15.79 million | Q1 2018: $15.39 million | Q2 2018: $14.33 million | Q3 2018: $12.23 million | Q1 2019: $8.62 million | Q2 2019: $7.31 million | Q3 2019: $7.91 million | Q1 2020: $14.29 million | Q2 2020: $37.13 million | Q3 2020: $36.19 million | Q1 2021: $43.54 million | Q2 2021: $39.93 million | Q3 2021: $43.10 million | Q1 2022: $64.92 million | Q2 2022: $58.07 million | Q3 2022: $53.93 million | Q1 2023: $53.86 million | Q2 2023: $46.01 million | Q3 2023: $37.15 million | Q1 2024: $49.44 million | Q2 2024: $38.28 million | Q3 2024: $92.95 million | Q1 2025: $153.77 million | Q2 2025: $133.57 million | Q3 2025: $126.44 million.
- Over the full 16 years of available data (2010 to 2025), CAPRICOR THERAPEUTICS, INC.'s Total Assets has grown by 9,609.6%.
- Historical annual values: Fiscal year 2025: $355.95 million | Fiscal year 2024: $170.48 million | Fiscal year 2023: $58.73 million | Fiscal year 2022: $50.09 million | Fiscal year 2021: $41.33 million | Fiscal year 2020: $34.62 million | Fiscal year 2019: $11.11 million | Fiscal year 2018: $9.25 million | Fiscal year 2017: $16.27 million | Fiscal year 2016: $18.75 million | Fiscal year 2015: $16.07 million | Fiscal year 2014: $13.63 million | Fiscal year 2013: $5.54 million | Fiscal year 2012: $5.42 million | Fiscal year 2011: $1.37 million | Fiscal year 2010: $3.67 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: